Enable Injections Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 193

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $30M

  • Investors
  • 14

Enable Injections General Information

Description

Operator of a healthcare innovation company intended to improve the patient treatment experience through the development of wearable drug delivery products. The company's devices are high-volume injectors that utilize any standard container closure system, including a syringe, vial, or cartridge, enabling patients to easily, comfortably, and control self-administration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2863 East Sharon Road
  • Cincinnati, OH 45241
  • United States
+1 (513)
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Corporate Office
  • 2863 East Sharon Road
  • Cincinnati, OH 45241
  • United States
+1 (513)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enable Injections Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B1) 09-Jan-2026 $30M Completed Generating Revenue
7. Later Stage VC (Series C) 25-Jan-2022 Completed Generating Revenue
6. Debt - General 08-Sep-2020 Completed Generating Revenue
5. Debt - PPP 15-Apr-2020 Completed Generating Revenue
4. Later Stage VC (Series B) 25-Oct-2018 Completed Generating Revenue
3. Later Stage VC (Series A) 05-Oct-2016 Completed Generating Revenue
2. Debt - General 15-Jan-2016 Completed Generating Revenue
1. Grant $500K Completed Startup
To view Enable Injections’s complete valuation and funding history, request access »

Enable Injections Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A 9,363,879 $0.001000 $0.26 $3.28 $3.28 1x $3.28 20.15%
To view Enable Injections’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enable Injections Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a healthcare innovation company intended to improve the patient treatment experience through the development
Drug Delivery
Cincinnati, OH
193 As of 2025

Chipping Norton, United Kingdom
 

Hackettstown, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enable Injections Competitors (10)

One of Enable Injections’s 10 competitors is Owen Mumford, a Corporate Backed or Acquired company based in Chipping Norton, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Owen Mumford Corporate Backed or Acquired Chipping Norton, United Kingdom
Flowonix Formerly VC-backed Hackettstown, NJ
SHL Medical Private Equity-Backed Zug, Switzerland
Subcuject Venture Capital-Backed Viby Sj, Denmark
Abiomed Corporate Backed or Acquired Danvers, MA
You’re viewing 5 of 10 competitors. Get the full list »

Enable Injections Patents

Enable Injections Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026232086-A1 Filter device with bubble control and method Pending 02-May-2025
WO-2026085418-A1 Fill amplification structure for injection devices Pending 18-Oct-2024
WO-2026024729-A1 Injection device trainer Pending 23-Jul-2024
WO-2026010964-A1 Methods and systems for monitoring an injection site reaction Pending 03-Jul-2024
WO-2026006404-A1 Devices and methods for body fluid collection Pending 27-Jun-2024 A61M5/14248
To view Enable Injections’s complete patent history, request access »

Enable Injections Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enable Injections Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
GCM Grosvenor Asset Manager Minority
Lightship Capital (Ohio) Venture Capital Minority
Magnetar Capital Hedge Fund Minority
Squarepoint Capital Hedge Fund Minority
Angel Physicians Fund Angel Group Minority
You’re viewing 5 of 14 investors. Get the full list »

Enable Injections FAQs

  • When was Enable Injections founded?

    Enable Injections was founded in 2010.

  • Where is Enable Injections headquartered?

    Enable Injections is headquartered in Cincinnati, OH.

  • What is the size of Enable Injections?

    Enable Injections has 193 total employees.

  • What industry is Enable Injections in?

    Enable Injections’s primary industry is Drug Delivery.

  • Is Enable Injections a private or public company?

    Enable Injections is a Private company.

  • What is the current valuation of Enable Injections?

    The current valuation of Enable Injections is .

  • What is Enable Injections’s current revenue?

    The current revenue for Enable Injections is .

  • How much funding has Enable Injections raised over time?

    Enable Injections has raised $342M.

  • Who are Enable Injections’s investors?

    GCM Grosvenor, Lightship Capital (Ohio), Magnetar Capital, Squarepoint Capital, and Angel Physicians Fund are 5 of 14 investors who have invested in Enable Injections.

  • Who are Enable Injections’s competitors?

    Owen Mumford, Flowonix, SHL Medical, Subcuject, and Abiomed are some of the 10 competitors of Enable Injections.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process